July 24, 2014 9:55 AM ET

Pharmaceuticals

Company Overview of Santarus, Inc.

Executive Profile

Alessandro E. Della Chà LL.M

Chief Executive Officer and Director, Cosmo Pharmaceuticals S.p.A.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
51$100,000

Background

Mr. Alessandro Della Chà, LLM, has been the Chief Executive Officer of Cosmo Pharmaceuticals S.p.A. since March 27, 2014. Mr. Chà is a Senior Partner at Studio Legale Edoardo Ricci e Associati, Milan. Mr. Chà specializes in company law, mergers and acquisitions. He joined the Studio Legale Edoardo Ricci e Associati in 1988. He served as an assistant of the central director for corporate matters of Fininvest Group from 1987 to 1988. He served as the Non-executive Vice ...

Corporate Headquarters

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-314-5700
Fax: 858-314-5701

Board Members Memberships

2006-Present
Chief Executive Officer and Director
2012-2014
Former Director

Education

Master's Degree
University of Leicester
LLB
Universita' degli Studi di Milano

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercised Options$40,236
Total Number of Options$40,236

Total Compensation

Total Annual Cash Compensation$100,000
Total Calculated Compensation$100,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Jack A. Khattar Founder, Chief Executive Officer, President, Secretary and Director
Supernus Pharmaceuticals, Inc.
$462.9K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Santarus, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.